New intelligence offerings provide the most accurate information to enable R&D professionals to develop better, faster clinical trials<br />
<br />
BOSTON – The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, revealed two new clinical trial intelligence software solutions today at the annual DIA meeting in Boston: Cortellis™ Clinical Trials Intelligence and Cortellis Site ...This story is related to the following:Test and Measuring InstrumentsSearch for suppliers of: Data Analysis Software | Clinical Analyzers